Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
19.08
+0.08 (0.42%)
Sep 14, 2026, 1:44 PM EDT - Market open
Surrozen Market Cap
Surrozen has a market cap or net worth of $224.26 million as of September 14, 2026. Its market cap has increased by 126.24% in one year.
Market Cap
224.26M
Enterprise Value
128.53M
1-Year Change
126.24%
Ranking
Category
Stock Price
$19.08
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $224.26M, an increase of 85.87%. That is a compound annual growth rate of 11.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 224.26M | 6.44% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 234.31M |
| Compugen | 233.97M |
| Veraxa Biotech AG | 233.32M |
| Invivyd | 231.53M |
| Adagene | 228.29M |
| Greenwich LifeSciences | 226.78M |
| Eledon Pharmaceuticals | 226.13M |
| Protara Therapeutics | 225.74M |